" class="no-js "lang="en-US"> Prashant Tandon - Medtech Alert
Tuesday, October 21, 2025

Breaking News

Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Astellas and Cullgen Enter into Strategic Collaboration and Option Agreement to Advance Innovative Targeted Protein Degraders Auxilius Pharma Raises Seed Funding of $1 Million and Commences its Clinical Program Captivate Bio and EverCell Bio partner on Human Cell Modeling Services for Cell and Gene Therapy Markets Applied StemCell Partners with CIRM to Provide Clinical-Grade iPSCs and Access to Its Proprietary Gene Editing Technologies Alentis Therapeutics Receives IND Clearance from FDA for ALE.C04 for the Treatment of CLDN1+ Tumors
Prashant Tandon

Prashant Tandon

About Prashant Tandon

Building a healthcare technology company in India.

Specialties: Management consulting, Start-ups, Operations management, Negotiations, Strategy, General Management, Technology, Sales & Marketing

Related Story

Industry News

 Tata Digital to Acquire Majority Stake in India’s Leading Online Healthcare Marketplace 1MG | Pharmtech Focus

Tata Digital to Acquire Majority Stake in India’s Leading Online Healthcare Marketplace 1MG

June 10 2021

Tata Digital Limited, a 100% subsidiary of Tata Sons Private Limited, will acquire a majority […]